ad image
Achieving Scalable and Sustainable Precision Fermentation Using Process Analytical Technology
Fermentation
Feb 27, 2025

Achieving Scalable and Sustainable Precision Fermentation Using Process Analytical Technology

Hamilton’s Charlotte Hughes, Ph.D. discusses how precision fermentation is reshaping biologic manufacturing by enabling the efficient production of high-value biomolecules using genetically engineered microorganisms

Five Small Biotechs to Watch: March 2025
Small Biotechs
Feb 28, 2025

Five Small Biotechs to Watch: March 2025

This month, Pharma’s Almanac highlights five emerging biotech startups — Tegmine Therapeutics, Latent Labs, Manas AI, Constructive Bio, and HaemaLogiX — pioneering advancements in oncology, AI-driven drug discovery, synthetic biology, and immunotherapy, shaping the future of biotechnology.

Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Financial Literacy
Mar 14, 2025

Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment

Emilee Kudla reimagines what a business could look like if collaboration, transparency, and shared success were actually built into the foundation.

Overcoming Challenges to High-Concentration Formulation Development
Formulation
Mar 02, 2025

Overcoming Challenges to High-Concentration Formulation Development

Samsung Biologics' Heonchang Lim discusses the S-HiCon™ platform, a systematic, science-driven approach designed to optimize high-concentration formulations through advanced analytical techniques, strategic risk mitigation, and stepwise process development.

Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing
xRNA
Feb 13, 2025

Revolutionizing xRNA Production: The Economic Case for Continuous Manufacturing

ReciBioPharm's Aaron B. Cowley discusses how ReciBioPharm is tackling the high costs and lengthy timelines in the development and manufacture of xRNA therapeutics and vaccines with its continuous manufacturing platform.

Meeting the Complex Challenges of Micronization with Experience and Technology
Micronization
Feb 25, 2025

Meeting the Complex Challenges of Micronization with Experience and Technology

TJ Higley, CEO of Microsize, discusses evolving industry needs for overcoming the solubility challenges that dominate today’s small molecule drug pipelines, the company’s unique capabilities, and the future of micronization in pharmaceutical development.

The White House’s War on the NIH and the Disasters Ahead
NIH
Mar 24, 2025

The White House’s War on the NIH and the Disasters Ahead

Now is the time for scientists, policymakers, and the public to unite in defense of the NIH and the future of scientific integrity.

Unlocking the Potential of Psychedelics for Postpartum Depression
Psychedelics
Mar 31, 2025

Unlocking the Potential of Psychedelics for Postpartum Depression

In this Q&A, Reunion Neuroscience President and CEO Greg Mayes discusses RE104, a novel prodrug designed to offer the benefits of psilocybin with a shorter duration and improved pharmacokinetics in clinical studies for postpartum depression.

Partners for Life: Driving Excellence through Trust and Collaboration
Partnerships
Mar 05, 2025

Partners for Life: Driving Excellence through Trust and Collaboration

FUJIFILM Diosynth Biotechnologies' President and CEO Lars Petersen explains how, by investing in state-of-the-art facilities and building a people-first culture, the company is positioning itself as the future of biopharmaceutical manufacturing.

Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
LOGIC GATES
Mar 14, 2025

Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies

Inspired by Boolean logic, logic-gated cell and gene therapies are designed to activate therapeutic responses only when specific combinations of biological signals are present, thereby enhancing precision and reducing unintended toxicity

Recommended

Verista to Showcase COUNTQ® Tray Inspection Systems at INTERPHEX 2025
Tray Inspection
Mar 24, 2025
Verista to Showcase COUNTQ® Tray Inspection Systems at INTERPHEX 2025
BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis
HPAPI
Mar 25, 2025
BioDuro Opens Shanghai Laboratory for Highly Potent Compound Synthesis
Public Statement on Supporting Science for the Benefit of All Citizens
Open Letter
Mar 31, 2025
Public Statement on Supporting Science for the Benefit of All Citizens

Spotlight

Conversations with Carleone: Leadership Wisdom Worth Sharing
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
The Valuation Equation: Speculating on Why Marketing and Communication Might Matter More than You Think
Five Small Biotechs to Watch: March 2025
ad image
ad image

THAT'S NICE TURNS 30: THREE DECADES OF BIOPHARMA AND THE ROAD TO THE FUTURE

featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content
featured content

Nice Insights

Magnetogenetics and the Future of Remote Biological Control
Magnetogenetics
Mar 17, 2025
Magnetogenetics and the Future of Remote Biological Control
Biotech Funding Ups and Downs
Nice Insight Reports
Apr 02, 2024
Biotech Funding Ups and Downs
Biotech Training is a Challenge
Training
Jun 11, 2024
Biotech Training is a Challenge
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Federal Job Cuts
Feb 19, 2025
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Rising Interest in Radioconjugate Therapies
Radioconjugates
Feb 25, 2025
Rising Interest in Radioconjugate Therapies
The Collapse of USAID-Funded Clinical Trials: A Blow to Global Health and Biopharma Innovation
USAID Trials
Feb 06, 2025
The Collapse of USAID-Funded Clinical Trials: A Blow to Global Health and Biopharma Innovation
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Drug Delivery
Aug 30, 2024
Nanocarriers to Overcome the Blood–Brain Barrier (BBB)
Conversations with Carleone: Leadership Wisdom Worth Sharing
Leadership Wisdom
Mar 14, 2025
Conversations with Carleone: Leadership Wisdom Worth Sharing
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Financial Literacy
Mar 14, 2025
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
LOGIC GATES
Mar 14, 2025
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
The Valuation Equation: Speculating on Why Marketing and Communication Might Matter More than You Think
Marketing
Feb 13, 2025
The Valuation Equation: Speculating on Why Marketing and Communication Might Matter More than You Think
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
Sustainability
Jan 02, 2025
Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive
ad image

IMPACT

#1

NIH

The White House’s War on the NIH and the Disasters Ahead
#2
#3
#4
#5
ad image

Roundtable

View all roundtable
RoundTable Topics
D
ARTIFICIAL INTELLIGENCE
Is AI truly transforming drug development, or are we still navigating through the hype?
M
Murray McKinnon, Ph.D.
R
Richard Lee, Ph.D.
A
Alan Marcus
C
Christian Olsen
M
Mark J. Kiel, M.D., Ph.D.
S
Simon Wagschal, Ph.D.
The real value of AI lies in its ability to explore what was once considered undruggable, unlocking new opportunities for innovation.
View all Answers
ad image

Editor's Picks

Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
Biomanufacturing
Nov 11, 2024
Transforming xRNA Manufacturing with Digital Technologies and Continuous Processing
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
NIH Funding
Feb 10, 2025
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Federal Job Cuts
Feb 19, 2025
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
Five Small Biotechs to Watch: March 2025
Small Biotechs
Feb 28, 2025
Five Small Biotechs to Watch: March 2025
Conversations with Carleone: Leadership Wisdom Worth Sharing
Leadership Wisdom
Mar 14, 2025
Conversations with Carleone: Leadership Wisdom Worth Sharing
Rising Interest in Radioconjugate Therapies
Radioconjugates
Feb 25, 2025
Rising Interest in Radioconjugate Therapies
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Financial Literacy
Mar 14, 2025
Employees Who Think Like Stakeholders: The Power of Transparency and Empowerment
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
LOGIC GATES
Mar 14, 2025
Boolean Biology: The Future of Logic-Gated Cell and Gene Therapies
Magnetogenetics and the Future of Remote Biological Control
Magnetogenetics
Mar 17, 2025
Magnetogenetics and the Future of Remote Biological Control
Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
Autoimmune Diseases
Dec 11, 2024
Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities
Unlocking the Potential of Psychedelics for Postpartum Depression
Psychedelics
Mar 31, 2025
Unlocking the Potential of Psychedelics for Postpartum Depression
Protein Science and the Future of Biotherapeutics
Bbiotherapeutics
Jan 22, 2025
Protein Science and the Future of Biotherapeutics
ad image

Videos

View all videos
Precision Medicine
Nov 15, 2024

Advancing Personalized Medicines and Precision Therapeutics

Kym Baker, General Manager, Pharma Services at Thermo Fisher Scientific, discusses how the Pharma Services group is helping biotech innovators developing personalized and precision biologics bring their therapeutics to life from early discovery to commercialization

Advancing Personalized Medicines and Precision Therapeutics
Precision Medicine
Nov 15, 2024
Advancing Personalized Medicines and Precision Therapeutics
Shining Light on the Communicable Disease Plight in Australia's Koalas
Koalas
Nov 15, 2024
Shining Light on the Communicable Disease Plight in Australia's Koalas
Exploring the Microbiome with Servatus
LBPs
Nov 18, 2024
Exploring the Microbiome with Servatus
Translating Academic Pursuits into Real-World Applications
Research
Nov 15, 2024
Translating Academic Pursuits into Real-World Applications
Building on Australia's Existing Biopharma Infrastructure
Biotherapeutics
Nov 15, 2024
Building on Australia's Existing Biopharma Infrastructure
Primal Organix's Nutraceutical Approach to Better Mental Health
Terpenes
Nov 12, 2024
Primal Organix's Nutraceutical Approach to Better Mental Health
Navigating the Australian Clinical Trials Landscape
Commissioning
Nov 15, 2024
Navigating the Australian Clinical Trials Landscape
Better Outcomes for Cancer Patients Begin with Screening
Diagnostics
Nov 15, 2024
Better Outcomes for Cancer Patients Begin with Screening
Leaps and Bounds for Synthetic Biology Startups
Synthetic Biology
Nov 15, 2024
Leaps and Bounds for Synthetic Biology Startups
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
Bioassays
Nov 12, 2024
State-of-the-Art, Multi-Modality Bioanalysis in Brisbane
QBI is Helping Translate Brain Research into Treatments
Neuroscience
Nov 15, 2024
QBI is Helping Translate Brain Research into Treatments
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab
Synthetic Biology
Nov 15, 2024
Queensland University of Technology's Cutting-Edge Synthetic Biology Lab

Latest

View all latest
Biotechs
Mar 31, 2025
Five Small Biotechs to Watch: April 2025
Supply Chain
Mar 31, 2025
Building Resilient Pharma Supply Chains in an Uncertain World
Psychedelics
Mar 31, 2025
Unlocking the Potential of Psychedelics for Postpartum Depression
Cell Therapy
Mar 26, 2025
Expanding the Frontiers of Cell Therapy: Veterinary Applications and Translational Insights
RNA
Mar 26, 2025
Is mRNA a Gene Therapy? Unpacking the Evolving Regulatory Debate
Drug Approvals
Mar 26, 2025
How can the industry balance the need for faster drug approvals with the necessity of ensuring patient safety and efficacy?
RNA
Mar 26, 2025
What new opportunities are emerging for mRNA technology, and how is the portfolio of applications expanding beyond vaccines?
NIH
Mar 24, 2025
The White House’s War on the NIH and the Disasters Ahead
ad image
ad image
Mammailan cell culture,Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

Mammailan cell culture,Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

Microbial Fermentation, Biologics: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE
Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

Antibody–Drug Conjugate, ADC: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

Sterile Fill Finish: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Gene Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

Cell Therapy: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

Messenger Ribonucleic Acid, mRNA: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

Plasmids Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

Active Pharmaceutical Ingredients, API: Market Insight, CDMO Pricing and Competitor Benchmarking

LEARN MORE
Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

Oral Solid Dose, OSD: Market Insight, CDMO Pricing and Benchmarking

LEARN MORE

Subscribe for the Newsletter

Pharma’s Almanac’s weekly newsletter, featuring industry news and must-read original content on a range of topics.

The Road To Series

030db6fe-32bf-4364-88b0-28655c88acf9
ea932e33-29ac-48c3-9e59-fea0994b10cc
cfe49a93-d81b-451e-9e07-8ba4ebfc53b8
8887a25b-41b6-430d-8d52-9722c7334914
2c58207c-1481-4629-bd23-de0d0815f2b1
e6bf6f4c-ce04-4ec3-9aa9-6c34b1c2494f